Psychiatric progress note example: an annotated medication management follow-up
The progress note is the note you write ten or more times a day, and it is exactly where documentation quality quietly decays. Nobody clones an intake. Follow-up notes get cloned constantly, because visit twelve feels like visit eleven and the clock is running. A good psychiatric progress note does not need to be long. It needs to prove four things in under a page: what changed since the last visit, the patient's current mental status, that risk was assessed, and a medication decision with a rationale.
What a psychiatric progress note has to do
Whether you are a psychiatrist or a PMHNP, every follow-up note carries the same load. The initial evaluation established the diagnosis (that structure is covered in the 90791 vs 90792 evaluation guide); the progress note tracks it forward. The working checklist:
- Interval history. What happened since the last visit, in this patient's words where possible: symptoms, adherence, side effects, life events.
- A brief mental status exam. Focused, not a full re-examination, and consistent with what the patient just told you.
- Risk assessment. SI, HI, and anything diagnosis-specific, documented every visit.
- Scale tracking where you use it. The score plus the trajectory, not a number floating in space.
- An assessment tied to the DSM diagnosis. Diagnosis, ICD-10 code, and where the patient sits in the treatment response.
- A plan with an explicit medication decision and rationale. Including deliberate continuation. "Continue sertraline 100 mg, tolerating well with sustained remission" is a decision; a bare refill is not.
- A follow-up interval. When you will see them again, and why that timing.
A therapist's progress note carries a related but distinct load, centered on interventions used, the patient's response, and progress toward treatment goals rather than medication decisions. Both matter; this article centers the prescriber follow-up.
The example note
The patient below is fictional. The ALL-CAPS headings are the structure OneStep Scribe actually emits for progress notes, shown here as a working template. This example uses the core sections; the full structure also includes primary stressors, substance use, goals and objectives, and a medical necessity justification.
Psychiatric follow-up note (established patient, week 6)
CHIEF COMPLAINT
"The edge is off, but I still spend the first hour of every workday dreading it." A.R. is a 28-year-old with generalized anxiety disorder presenting for follow-up. Last seen 6 weeks ago, at which time escitalopram 10 mg daily was initiated.
INTERVAL EVENTS
Since the last visit, A.R. reports partial improvement. Evening worry and sleep-onset rumination have clearly eased: "I can actually turn my brain off at night now." Morning anticipatory anxiety persists, worst before team meetings in her new project lead role. Taking escitalopram daily with no missed doses; mild nausea in the first week resolved, and she denies other side effects.
PRIMARY SYMPTOM REVIEW
Excessive worry (Improving): Reduced in the evenings but persistent in the mornings. "It used to be all day. Now it burns off by lunch."
Muscle tension (Stable): "My shoulders are still up around my ears by noon."
Insomnia (Improving): Sleep onset now under 30 minutes most nights, previously 2 hours.
Functional impact: performing well in the new role but avoids volunteering in meetings; evenings and social functioning largely recovered.
RISK ASSESSMENT
Suicidal Ideation: Denies.
Homicidal Ideation: Denies.
Protective factors: engaged in treatment, supportive partner, future-oriented about career.
Overall risk level: Low. Calm, stable presentation with denial of ideation and intact protective factors.
MENTAL STATUS EXAMINATION
Alert and engaged, mood "better, not all the way there," affect congruent with a mild anxious undertone. Thought process linear and goal directed with no perceptual disturbances. No suicidal or homicidal ideation.
DIAGNOSTIC FORMULATION
F41.1 Generalized anxiety disorder
Trajectory: Improving
Partial response at 6 weeks on escitalopram 10 mg: worry and sleep meaningfully improved, with residual morning anticipatory anxiety and muscle tension that continue to affect work functioning.
PLAN
1. Increase escitalopram to 20 mg daily. Rationale: partial response at an adequate 6-week trial of 10 mg with good tolerability; optimizing the dose is preferred over switching given the clear early benefit. Reviewed common side effects and warning signs to report.
2. GAD-7 today: 11, down from 17 at initiation. Improvement consistent with reported gains; repeat at next visit to confirm response to the higher dose.
3. Follow up in 4 weeks to assess response; patient will call sooner if symptoms worsen or side effects emerge.
The five ways progress notes decay
- Carry-forward cloning. Yesterday's note with a new date. The tell is interval history that never changes and quotes that repeat verbatim across visits.
- Refill without rationale. "Continue current medications" with no statement of why. Continuation is a clinical decision and deserves one line of reasoning, even if it is just sustained remission and good tolerability.
- Missing or boilerplate risk assessment. Either no risk language at all, or the same "denies SI/HI" macro on every patient regardless of what was actually asked.
- An MSE that contradicts the HPI. "Mood euthymic" two paragraphs after the patient reported their worst month of the year. Reviewers read for internal consistency before anything else.
- Scales listed but never interpreted. A GAD-7 of 11 means nothing on its own. Down from 17, it is evidence of clinically meaningful improvement; the interpretation is the clinical work.
Do therapists need a different structure?
Yes in emphasis, no in discipline. A therapist's progress note centers the interventions used, how the patient responded, and progress toward treatment goals, rather than medication decisions. The underlying standard is identical: session-specific content, risk documented, goals tracked over time. OneStep Scribe drafts both formats.
Frequently asked questions
How long should a psychiatric progress note be?
Long enough to prove the four things: interval change, current mental status, risk, and a reasoned medication decision. For most follow-ups that is well under a page. Length is not quality, and padding a note does not make it more defensible.
Do I need a full MSE every visit?
A brief, focused MSE is standard at every visit. Full detail belongs where it is clinically indicated: new patients, significant status changes, safety concerns, or diagnostic uncertainty.
Can I copy forward my last note?
Carrying forward static history, such as past medications or family history, is common practice. But every clinical element, including interval history, MSE, risk, and plan, must be re-verified and updated at each visit. Cloned notes are a recognized audit flag.
Should scales go in every note?
When you use them, chart the score and interpret the trajectory; a raw number without context does no work. How often you administer them depends on your workflow and on any payer measurement programs you participate in.
What about time documentation?
If you bill the E/M on MDM, a time statement is optional. If you bill a psychotherapy add-on, the psychotherapy minutes must be stated separately from E/M work; the billing guide walks through the rules.
OneStep Scribe listens to the visit and drafts progress notes, evaluations, and SOAP notes in this structure, with the patient's own words, for psychiatrists, PMHNPs, therapists, and psychologists. Every account is NPI-verified, and every note is yours to review and sign.
Start a 14-day free trialThis article is educational and reflects one clinician's documentation approach. It is not legal, billing, or payer-specific advice, and it does not guarantee reimbursement. CPT is a registered trademark of the American Medical Association. The patient described is fictional. Always verify requirements with your payers and compliance advisors.